Compare CDMOs with FDA registration for US-market pharmaceutical manufacturing. Filter by product type, inspection history, and manufacturing capabilities.
731 companies listed
Switzerland
Zile Bonbons AG is a Swiss specialist contract manufacturer of lozenges, chews, and dragees for the pharmaceutical (OTC), nutraceutical, dietary supplement, and confectionery industries. Headquartered in Rupperswil, Switzerland, they have a dedicated OTC lozenges manufacturing plant. They provide full-service contract development and manufacturing from product conception through commercial production, including formulation development, prototyping, sourcing, manufacture, packaging, and logistics. Their technologies include stamping, cutting, moulding, and coating, with primary packaging options (wrapper/flow pack, bags, flip-top boxes, bars, blisters). They manufacture alternative drug delivery systems as centre-filled OTC lozenges with precise API dosage. They have pharmaceutical GMP expertise and are FDA-registered (FEI 3003236010) with 1 FDA inspection (VAI). Classified as CMO rather than CDMO because their development work is focused on lozenge formulation for third parties, but they do not position themselves as offering full drug development services beyond the lozenge/chew format.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Finland
3P Biovian is a global biologics CDMO providing end-to-end services from early-stage development to commercialization. They specialize in proteins, viral vectors, plasmid DNA, and cell therapy products with cGMP manufacturing facilities in Turku, Finland, and Pamplona-Noain, Spain. The company has invested over 50 million euros in facility expansion.